- Preview Available
- Scholarly Journal
Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study
Cancer Immunology, Immunotherapy; Heidelberg Vol. 72, Iss. 3, (Mar 2023): 591-598.
DOI:10.1007/s00262-022-03281-7
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.